1 recruiting, 1 unknown. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Clinique du Quartier Latin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reducing Systemic Inflammation in People on Antiretroviral Therapy Fostemsavir - Human Immunodeficiency Virus (HIV), Cardiovascular Risk Factor | Phase 2 | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 150 | 2025-09-30 | 2025-11-19 |
| HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI Resistance Doravirine - HIV Infections | Phase 4 | Unknown | Clinique du Quartier Latin | 40 | 2020-06-23 | 2021-01-29 |
Acquired Immunodeficiency Syndrome (1) · HIV Infections (1)
doravirine (1) · fostemsavir (1)
Canada (2) · Martinique (1)